Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Terminal complement activation is increased and associated with disease severity in CIDP.
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system.
Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery.
Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
Disease modifying therapies for relapsing multiple sclerosis.
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition.
Disease-Modifying Drug Possibly Linked to Placental Insufficiency: Severe placental complications in a pregnant woman with multiple sclerosis.
Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis.
A case of POEMS mimicking a "Guillain-Barré like" syndrome.
Cre inducible site-specific recombination in zebrafish oligodendrocytes.
Multiple sclerosis and employment: Associations of psychological factors and work instability.
Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study.
LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).
Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
The relation of multiple sclerosis with allergy and atopy: a case control study.
Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
Calcium CaV1 Channel Subtype mRNA Expression in Parkinson's Disease Examined by In Situ Hybridization.
Current trends in autoimmunity and the nervous system.
B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses.
Evaluation of Handwriting Movement Kinematics: From an Ecological to a Magnetic Resonance Environment.
Effect of Lipopolysaccharide Derived from Pantoea agglomerans on the Phagocytic Activity of Amyloid β by Primary Murine Microglial Cells.
Polygenic control of autoimmune peripheral nerve inflammation in rat.
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.
Oligodendrocyte ablation as a tool to study demyelinating diseases.
Pages
« first
‹ previous
…
746
747
748
749
750
751
752
753
754
…
next ›
last »